Trading in Novo Nordisk shares by board members, executives and associated persons on 5 – 8 February 2020

Bagsværd, Denmark, 10 February 2020 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of EU Regulation No. 596/2014 on market abuse.Further information
AttachmentCA200210_Insider Trading